Phramongkutklao Hospital is a hospital located in Ratchathewi District, Bangkok, Thailand. It is a military hospital for the Royal Thai Army and a teaching hospital for Phramongkutklao College of Medicine which trains doctors for the Royal Thai Armed Forces, as well as the Royal Thai Army Nursing College.

There are 1,200 beds in Phramongkutklao Hospital.

During the past decade, Phramongkutklao Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Phramongkutklao Hospital" #1 sponsor was "Phramongkutklao College of Medicine and Hospital" with 4 trials, followed by "Arena Pharmaceuticals" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "National Cancer Institute, Thailand" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phramongkutklao Hospital" #1 collaborator was "Silpakorn University" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Vichaiyut Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Phramongkutklao Hospital" are "Ulcerative Colitis" (3 trials), "Peritoneal Dialysis-related Infection" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Cancer Cachexia" (1 trials) and "Carcinoma Breast Stage IV" (1 trials). Many other conditions were trialed in "Phramongkutklao Hospital" in a lesser frequency.

Most popular intervention types in "Phramongkutklao Hospital" are "Drug" (7 trials), "Other" (2 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Etrasimod" (3 trials), "BI 655064" (1 trials), "BI 695501" (1 trials) and "Curcumin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Phramongkutklao Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Phramongkutklao Hospital". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Phramongkutklao Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Phramongkutklao Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".